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Introduction {#sec1}
============

Brown adipocytes (BAs) have unique roles in energy expenditure and non-shivering thermogenesis, which is contrary to white adipocytes (WAs) that store excess energy obtained from food in the form of lipids ([@bib5], [@bib3]). The BAs specifically express uncoupling protein 1 (UCP1) at the mitochondrial inner membrane to dissipate the electrochemical proton gradient as heat, playing a pivotal role in regulation of body temperature, energy balance, and adiposity. In rodents, BAs prevent diet-induced obesity, insulin resistance, and type II diabetes ([@bib20]). Until recently, however, the significance of BAs in human remained controversial, because BAs are rarely detectable in the adult human. Since 2009, positron emission tomography (PET) using ^18^F-fluorodeoxyglocose (FDG) has clearly visualized metabolically active brown adipose tissue (BAT) in supraclavicular, mediastinal, paravertebral, and perirenal regions characterized by robust uptake of ^18^F-FDG upon acute cold exposure ([@bib31], [@bib42], [@bib4]). Interestingly, the BA activity considerably varies from person to person and correlates inversely with age, fasting plasma glucose levels, and BMI ([@bib31], [@bib27], [@bib28]). These findings strongly suggest the importance of BAs in physiological regulation of the whole-body energy balance and body fat accumulation, as well as the pathophysiology of obesity and metabolic diseases in humans. If human BAs with high energy expenditure activity can be artificially generated, the technology may greatly facilitate basic as well as applied research of these BAs. Especially, transplantation of such BAs may provide a regenerative therapy to control metabolic diseases, including diabetes mellitus.

Yamanaka's group demonstrated that mammalian somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) with embryonic-stem-cell-like characteristics by transducing genes for transcription factors, *Octamer-binding transcription factor 3/4* (*OCT4*), *SOX2*, *KLF-4*, and *C-MYC* (so called reprogramming factors; [@bib37], [@bib38]), strongly suggesting that a small number of key transcription factors may globally change epigenetic programming in somatic cells to convert their fates ([@bib22], [@bib30]). More recently, somatic cells were redirected into another differentiated cell lineage, without passing an intermediate pluripotent stage, by transducing a set of transcription factors that play crucial regulatory roles in the differentiation of the destination cell; direct conversion, or direct reprogramming, of murine fibroblasts into cardiomyocytes ([@bib11], [@bib13], [@bib12]), neurons ([@bib18], [@bib19], [@bib2], [@bib8]), chondrocytes ([@bib9]), and hepatocytes ([@bib34], [@bib10]), as well as of human fibroblasts into cardiomyocytes ([@bib43], [@bib24]), neurons ([@bib29], [@bib2], [@bib19]), and hematopoietic cells ([@bib36]) have been reported. Although the efficiencies of direct conversion were generally low (0.005%--30% of fibroblasts were successfully converted into the cells of interest; [@bib39], [@bib34], [@bib29], [@bib24], [@bib18], [@bib19], [@bib13], [@bib12], [@bib11], [@bib10], [@bib8], [@bib2]), these technologies may be quite valuable for generation of the desired cells that could be used in basic research as well as in regenerative therapy for various human disorders. We have recently succeeded in directly reprogramming human fibroblasts into osteoblasts that massively produced bone matrix and contributed to bone regeneration with an efficiency as high as 80% ([@bib44]).

In the current study, we directed our efforts to generate BAs from iPSCs and fibroblasts by introducing the genes that play central roles in BA development as well as in somatic cell reprogramming and analyzed their functions in culture and transplanted animals.

Results {#sec2}
=======

iBAs Induced from iPSCs Suppressed Obesity and Diabetes {#sec2.1}
-------------------------------------------------------

Human iPSCs were cultured with retinoic acid (RA) at doses of 25 μM (initial 7 days) and 50 μM (next 10 days), followed by transduction of the gene encoding the PRDM16 (PRD1-BF1-RIZ1 homologous domain containing 16) that was reported as the key regulator of BA differentiation ([@bib32], [@bib33]). After culturing for another 12 days, approximately 75% of the cells showed BA-like appearance characterized by multilocular lipid droplets and abundant mitochondria ([Figure 1](#fig1){ref-type="fig"}A). The cells highly expressed *UCP1*, *CIDEA*, and *DIO2* genes that are known to be specifically expressed in BAs ([Figures 1](#fig1){ref-type="fig"}B and 1C). Stimulation of these cells (namely iBAs) with isoproterenol, a general agonist of β-adrenergic receptors, resulted in further elevation of expression level of *UCP1* mRNA, which is a typical adrenergic response of BAs ([Figure 1](#fig1){ref-type="fig"}D). The human iBAs showed remarkably high rates of oxygen consumption and uncoupling respiration ([Figure 1](#fig1){ref-type="fig"}E).

We obtained mouse iBAs as above and assessed their metabolic activities in vitro and in vivo. The mouse iBAs expressed *Ucp1* and *Cidea* mRNA at comparable levels to those in the BAT ([Figure S1](#mmc1){ref-type="supplementary-material"}A). They were rich in lipid deposits and mitochondria ([Figure S1](#mmc1){ref-type="supplementary-material"}B) and showed a high rate of uncoupling respiration ([Figure S1](#mmc1){ref-type="supplementary-material"}C). The iBAs were subcutaneously transplanted into syngenic mice, and their heat-producing activity was measured. As shown in [Figure 2](#fig2){ref-type="fig"}A, cold exposure resulted in heat production at site of the graft. Histological examinations revealed the presence of Oil Red O-positive iBAs in the graft ([Figure 2](#fig2){ref-type="fig"}B).

The mice transplanted with iBAs were given a high-fat diet. A shown in [Figure 2](#fig2){ref-type="fig"}C, they gained body weight less significantly than controls. Serum lipid analyses indicated that the dyslipidemia caused by high-calorie diet was significantly restored by the iBA transplantation ([Figure 2](#fig2){ref-type="fig"}D).

Next, experiments were performed to confirm the effect of iBAs on metabolic aberration using a different mouse model, i.e., type 2 diabetic KK-Ay mice ([@bib17], [@bib40], [@bib26]). iPSCs were established from fibroblasts of KK-Ay mice ([Figure S2](#mmc1){ref-type="supplementary-material"}), and iBAs induced from the iPSCs were transplanted into syngenic hosts. As shown in [Figures 2](#fig2){ref-type="fig"}E and 2F, the iBA-transplanted mice showed significantly lower body weight gain and serum glucose elevation. The iBA transplantation also reduced urine glucose ([Figure 2](#fig2){ref-type="fig"}G) and serum levels of total cholesterol, LDL cholesterol, triglycerides (TGs), phospholipid, and non-esterified fatty acids (NEFA) ([Figure 2](#fig2){ref-type="fig"}H). Although HDL cholesterol level was not significantly affected, the ratio of HDL/total cholesterol was remarkably increased by the iBA transplantation ([Figure 2](#fig2){ref-type="fig"}H).

These results demonstrated that iBAs were metabolically active in vivo and significantly suppressed diet-induced obesity, dyslipidemia, and type 2 diabetes.

Direct Conversion of Fibroblasts into BAs {#sec2.2}
-----------------------------------------

We next tried to directly convert human fibroblasts into BAs. Retroviral vectors containing the *PRDM16* (*P*) and *C/EBP-β* (*C*) genes, as well as those containing the reprogramming factor genes (*Klf4* \[*K*\], *L-MYC* \[*L*\], *C-MYC* \[*M*\], and *Glis1* \[*G*\]) were prepared, and various combinations of the retroviral vectors were infected into dermal fibroblasts. Oil Red O staining suggested that some combinations of genes, such as *PCLMG*, *CLMG*, *PCLM*, *CLM*, and *CM*, strongly evoked fibroblasts to accumulate lipid droplets ([Figure S3](#mmc1){ref-type="supplementary-material"}A).

Thus, we transduced *PRDM16*, *C/EBP-β*, and/or *C-MYC* genes to the cells and examined the efficiency of induction of BA-like characteristics in more detail. The results are shown in [Figures 3](#fig3){ref-type="fig"}A and 3B. Oil Red O-positive lipid droplets were only faintly induced in *C*- and *PC*-transduced cells. Meanwhile, the *PCM* mixture more drastically induced accumulation of the lipid depots and an increase in number of mitochondria in the cells. Interestingly, the combination *CM* converted fibroblasts into cells with a BA-like phenotype at the highest rate.

Cells transduced with *C* and/or *M* were tested for mRNA expression of endogenous *PRDM16*, *C/EBP-β*, and *C-MYC* genes. Exogenous *C/EBP-β* induced endogenous *C/EBP-β*, whereas both *C/EBP-β* and *C-MYC* were required for induction of *PRDM16* ([Figure 3](#fig3){ref-type="fig"}C). Thus, *CM* transduction induced endogenous *C/EBP-β* and *PRDM16* gene expression, which may have caused conversion of fibroblasts into BA-like cells. Fibroblasts expressed endogenous c-*myc* mRNA at low level, which was not affected by transduction with *C* and/or *M*.

The *CM*-transduced cells were referred to as directly converted BAs (dBAs) and examined in more detail. Immunostaining showed that the dBAs highly expressed BA-specific proteins ([Figure 3](#fig3){ref-type="fig"}D). It was found that 92.1% ± 12.1% of the fibroblasts became UCP1-positive cells ([Figure 3](#fig3){ref-type="fig"}E). The cells expressed mRNA for *UCP1*, *CIDEA*, and *ADIPOQ* at extremely high levels compared with fibroblasts. The mice BAT expressed comparable levels of mRNA for these genes ([Figure 3](#fig3){ref-type="fig"}F).

We also performed DNA microarray analysis to examine genome-wide mRNA expression profiles. Hierarchical clustering analysis revealed that gene expression profile of dBAs was closer to that of iBAs than those of fibroblasts and WAs ([Figures 4](#fig4){ref-type="fig"}A and 4B).

We analyzed the effects of *CM* transduction on the epigenetic status of BA-related genes. In untransduced fibroblasts, genomic DNA was heavily methylated at CpG dinucleotides at the upstream regions of the *PPARγ* (*peroxisome proliferator-activated receptor-γ*) and *UCP1* gene loci. In sharp contrast, the CpG sequences were mostly unmethylated 12 days after *CM* transduction ([Figure 4](#fig4){ref-type="fig"}C).

Functional features of the dBAs were assessed in vitro. As shown in [Figure 5](#fig5){ref-type="fig"}A, the copy number of mitochondrial DNA rapidly increased after *CM* transduction of fibroblasts, which was consistent with an increase in the number of mitochondria ([Figure 3](#fig3){ref-type="fig"}A). Addition of leptin and isoproterenol prompted dBAs to highly express mRNA for *UCP1* and the *leptin receptor* (*LEPR*) ([Figures 5](#fig5){ref-type="fig"}B and 5C). dBAs consumed more glucose than fibroblasts, as indicated by the decrease in glucose content in the culture medium ([Figure 5](#fig5){ref-type="fig"}D) and uptake of 2-deoxy glucose (2DG) ([Figure 5](#fig5){ref-type="fig"}E). The glucose uptake by dBAs was further elevated after stimulation with insulin, which in turn could be inhibited by phloretin, an inhibitor of the glucose transporter, and antimycin, a suppressor of the electron transport chain. dBAs also showed a higher rate of oxygen consumption than fibroblasts ([Figure 5](#fig5){ref-type="fig"}F). The oxygen uptake of dBAs was only partially suppressed by oligomycin, an inhibitor of mitochondrial ATP synthase, demonstrating a high rate of uncoupling respiration. It is virtually impossible to obtain viable BAs from human BAT and culture them for functional analyses; therefore, metabolic activity of human BAs has not been fully evaluated. Our results indicated that human dBAs were highly active in mitochondrial biogenesis and oxidative metabolism.

We examined whether dBAs were actually converted from fibroblasts without passing an immature pluripotent stage. After transduction with *CM*, fibroblasts were immunostained with anti-NANOG antibody every day during days 1--5 post-transduction. No significant expression of NANOG, which is an essential transcription factor for pluripotent cells, was detected at all during the experimental periods, whereas UCP1 was detected as early as day 5 ([Figure S3](#mmc1){ref-type="supplementary-material"}B). These results suggest that dBAs were directly converted from fibroblasts.

The dBAs expressed retroviral *C/EBP-β* and *C-MYC* transgenes at high levels ([Figure S4](#mmc1){ref-type="supplementary-material"}A). We assessed whether continuous expression of these exogenous genes is required for dBAs to maintain their phenotype. Using the Tet-On promoter system, fibroblasts were allowed to express retroviral *C* and *M* genes only during the first 20 days, followed by culturing for another 22 days without induction of the exogenous gene expression. Because the Tet-On promoter achieved relatively low levels of expression of *C* and *M* genes even in the presence of doxycycline, efficiency of conversion was lower than that obtained by conventional *CM* retrovirus vectors; thus, we picked up colonies with lipid droplets for qRT-PCR analysis. As results, the cells retained the BA-like character on day 42 ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C), although they no longer expressed exogenous *C* and *M* genes ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Therefore, dBAs, once established by transient *CM* expression, may have developed intrinsic program that stably maintained the dBA phenotype even in the absence of the exogenous gene expression.

We tried to convert mouse fibroblasts into dBAs. Interestingly, transduction of *CM* that successfully converted human fibroblasts into dBAs failed to significantly induce *Ucp1* mRNA in MEFs (mouse embryonic fibroblasts) per se, whereas *PCL* was found the most-effective gene combination for mouse dBA direct reprogramming ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Transduction of *CM* and *CL* induced expression of *PRDM16* in human ([Figures 3](#fig3){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}B, lower), but not mouse ([Figure S5](#mmc1){ref-type="supplementary-material"}B, upper), fibroblasts, which may be the reason why exogenous *Prdm16* is required for the conversion of mouse fibroblasts into dBAs. The *PCL*-transduced cells (mouse dBAs) expressed *Ucp1* and *Cidea* mRNA as strongly as mouse BAT ([Figure S5](#mmc1){ref-type="supplementary-material"}C) and shared similar gene expression profiles with mouse BAT, but not with MEFs ([Figure S5](#mmc1){ref-type="supplementary-material"}D). The mouse dBAs also showed high rates of basal oxygen consumption and uncoupling respiration ([Figure S5](#mmc1){ref-type="supplementary-material"}E).

dBAs Significantly Improved Metabolic Traits In Vivo {#sec2.3}
----------------------------------------------------

Mouse dBAs were subcutaneously transplanted into syngenic mice, and high-fat diet was given to them. The diet-induced obesity was remarkably prevented by the dBA transplantation ([Figure 6](#fig6){ref-type="fig"}A). Glucose tolerance and insulin sensitivity were significantly improved as early as 2 weeks after the dBA transplantation ([Figure 6](#fig6){ref-type="fig"}B), when body weights of mice did not significantly differ among groups ([Figure 6](#fig6){ref-type="fig"}A), strongly suggesting that the improvement in glucose tolerance and insulin sensitivity was not secondarily resulted from the suppression of body weight gain. Serum lipid analyses indicated that dBA transplantation reduced total cholesterol, LDL cholesterol, TG, phospholipid, and NEFA levels and significantly elevated the HDL/total cholesterol ratio ([Figure 6](#fig6){ref-type="fig"}C). The graft area showed high temperature ([Figure 6](#fig6){ref-type="fig"}D), suggesting that the dBAs may have expended the dietary energy as heat. Immunohistochemical analysis of graft tissue demonstrated tyrosine hydroxylase-positive cells ([Figure S6](#mmc1){ref-type="supplementary-material"}A), strongly suggesting sympathetic innervation of the dBA graft.

Finally, we investigated whether dBA transplantation affected insulin resistance and dyslipidemia in type 2 diabetes. KK-Ay diabetic mice were transplanted with dBAs obtained from syngenic MEFs. The mice showed significantly lower body weight gain ([Figure 7](#fig7){ref-type="fig"}A) and serum glucose levels ([Figures 7](#fig7){ref-type="fig"}B and 7C) compared with controls. The glucose tolerance of diabetic mice was significantly improved by the dBA transplantation, which also reduced insulin resistance ([Figures 7](#fig7){ref-type="fig"}D and 7E). Serum levels of total cholesterol, LDL cholesterol, TG, phospholipid, and NEFA were reduced by the dBAs as well ([Figure 7](#fig7){ref-type="fig"}F).

In an attempt to clarify the mechanism of suppression of insulin resistance by dBAs, some mice were grafted with dBAs that had been transfected with shRNA specific for *Ucp1*. The shRNA treatment suppressed *Ucp1* mRNA to approximately 14% ([Figure S6](#mmc1){ref-type="supplementary-material"}B). As result, the silencing of *Ucp1* significantly cancelled the effects of dBAs on body weight gain ([Figure 7](#fig7){ref-type="fig"}A), serum glucose levels ([Figures 7](#fig7){ref-type="fig"}B and 7C), glucose tolerance ([Figure 7](#fig7){ref-type="fig"}D), and dyslipidemia ([Figure 7](#fig7){ref-type="fig"}F).

Discussion {#sec3}
==========

Two different lineages of BAs have been known. Classical BAs are derived from *Myf-5* expressing common progenitors for myoblasts and BAs ([@bib33]). The myoblastic precursors originate from the mesenchymal stem cells (MSCs). *PRDM16* is crucially involved in the differentiation of myoblasts into classical BAs ([@bib32], [@bib33], [@bib15]). *PRDM16* interacts with *C/EBP-β* to form an active transcription complex that enhances expression of genes involved in brown adipogenesis, such as *PGC-1α* ([@bib15]). [@bib1] induced human iPSCs to differentiate into MSCs and subsequently transduced them with the *PPAR-γ2* and *C/EBP-β* (with/without *PRDM16*) genes. The resultant cells expressed *UCP1* approximately 20-fold higher than WAs ([@bib1]). [@bib25] cultured human iPSCs and ESCs with a cocktail of hematopoietins and succeeded in inducing the classical BAs. The cells improved oral fat and glucose tolerance of normal mice 16 hr after transplantation ([@bib25]). Our iBAs were induced from iPSCs via a myoblast-like state, and only *PRDM16* was required for the conversion of the myoblast-like cells into iBAs ([Figure 1](#fig1){ref-type="fig"}), which is consistent with previous literature on the contribution of *PRDM16* in differentiation of classical BAs ([@bib32], [@bib33], [@bib15]).

Meanwhile, inducible BAs, also referred to as brite (brown in white), beige, or brown-like adipocytes, are directly converted from MYF-5-negative adipocytes in white lipid depots ([@bib6], [@bib21], [@bib3]). The induction of the BA-like phenotype (browning) is caused by chronic cold exposure, hormonal or β-adrenergic signals, or pharmacological activation of PPAR-γ. Again, PRDM16 plays a crucial role in the browning; it binds to CTBP1 (C-terminal-binding protein 1) and CTBP2 to repress transcription of various WA-specific genes, whereas an association of PRDM16 with PGC-1α and PGC-1β results in induction of genes involved in BA differentiation ([@bib14]). It is also been shown that the vascular endothelium of adipose tissue can transdifferentiate into WAs and BAs ([@bib41]).

Unlike these physiological differentiation pathways of BAs, i.e., differentiation of classical BAs from MSCs via myoblasts, and transdifferentiation of inducible BAs from WAs, we succeeded in artificial conversion of unrelated somatic cells into highly functional BAs. In a previous report, not only myoblasts but also immortalized and normal fibroblasts were co-transduced with *PRDM16* plus *C/EBP-β* genes ([@bib15]). After the transduction, the immortalized mouse fibroblasts expressed *Ucp1* mRNA approximately 1,000-fold higher than untransduced cells, whereas normal human and mouse fibroblasts had approximately 7 and 20 times higher expression levels than untransduced ones, respectively. Mouse BAT expresses approximately 200,000 times higher *Ucp1* mRNA compared with fibroblasts that express this gene very faintly ([Figure 3](#fig3){ref-type="fig"}F). Our experiments also showed that *PRDM16* plus *C/EBP-β* (*PC*) very faintly induced the BA-like phenotype in human fibroblasts ([Figures 3](#fig3){ref-type="fig"}A and 3B). In contrast, the dBAs induced by *C/EBP-β* and *C-MYC* (*CM*) expressed *UCP1* mRNA approximately 100,000-fold higher than untransduced fibroblasts ([Figure 3](#fig3){ref-type="fig"}F) and showed a much more significant BA-like phenotype than *PC*-transduced cells ([Figures 3](#fig3){ref-type="fig"}A and 3B). Thus, C-MYC must have played an indispensable role in the reprogramming of normal fibroblasts into fully functional dBAs. C-MYC is one of the Yamanaka's reprogramming factors ([@bib37], [@bib38]), and although it is not a prerequisite for iPSCs generation ([@bib23]), C-MYC is shown to play important roles in direct reprogramming of mouse fibroblasts into neural stem cells ([@bib8], [@bib39]) and chondrocytes ([@bib9]). In our procedure, *C-MYC* induced *PRDM16* gene in cooperation with *C/EBP-β*, which may be crucial for reprogramming of fibroblasts into dBAs ([Figure 3](#fig3){ref-type="fig"}C).

The present study showed that transplantation of iBAs and dBAs markedly reduced diet-induced obesity, dyslipidemia, and insulin resistance in mice ([Figures 2](#fig2){ref-type="fig"}, [6](#fig6){ref-type="fig"}, and [7](#fig7){ref-type="fig"}). The dBAs controlled insulin resistance in an UCP1-dependent fashion, strongly suggesting the UCP1-mediated energy expenditure as the principal mechanism underlying the control of insulin resistance ([Figure 7](#fig7){ref-type="fig"}). [@bib7] transplanted BAT from mouse embryos into type 1 diabetic mice and showed significant suppression of diabetic markers. [@bib35] transplanted BAT from the interscapular region of adult mice into syngenic mice and found significant improvement in the high-calorie-diet-associated metabolic traits. The present study demonstrated artificial generation of highly functional BAs capable of controlling insulin resistance, dyslipidemia, and obesity.

The present study suggests the possibility of a cell therapy for the metabolic diseases using tailor-made BAs. Such regenerative therapies may be particularly efficacious to those patients who have lost functional BAT due to aging and/or progression of metabolic diseases ([@bib31], [@bib27]).

Experimental Procedures {#sec4}
=======================

Cells {#sec4.1}
-----

aHDF (normal human dermal fibroblasts) was purchased from Kurabo (cat no. KF-4109), whereas the PLAT-GP and PLAT E packaging cell lines were purchased from Cell Biolabs (cat nos. VPK-305 and VPK-303, respectively). They were cultured in Dulbecco's modified eagle medium (DMEM) (Nacalai Tesque) supplemented with 10% FBS, 100 mM non-essential amino acids (NEAA), 100 U/ml penicillin, and 100 μg/ml streptomycin (Complete medium). SNL feeder cells were purchased from DS Pharma Biomedical (cat no. EC07032801-F0). Human iPSCs were established from NHEK (human epidermal keratinocytes; cat no. FC-0025; Kurabo) by transfecting Epstein-Barr virus (EBV)-based episomal vectors encoding *OCT3/4*, *KLF-4*, *SOX2*, *C-MYC*, and LIN28 as described ([@bib38]). KK-Ay mouse iPSCs were established from tail tip fibroblasts by transduction with retroviral vectors containing murine *Oct3/4*, *Klf-4*, *Sox2*, and *C-myc* genes ([Figure S3](#mmc1){ref-type="supplementary-material"}). Every cell line had been determined to be negative for mycoplasma contamination.

Retroviral Vectors {#sec4.2}
------------------

The coding sequences for human *PRDM16* and *C/EBP-β* genes (DNAFORM cDNA clone library; DNAFORM) were amplified by RT-PCR and cloned into EcoRI-digested pMXs vector (Cell Biolabs). pMXs vectors containing human *Krueppel-like factor 4* (*KLF4*), *Glis family zinc finger 1* (*GLIS1*), *C-MYC*, and *L-MYC* genes were a kind gift of Professor S. Yamanaka (Kyoto University). PLAT-GP packaging cells (5.5 × 10^6^) were plated on geratin-coated 10-cm dishes and cultured overnight. They were co-transfected with pCMV-VSV-G and one of the pMX plasmids containing transcriptional factor genes as above using the X-treme Gene 9 transfection reagent (Roche Applied Science) diluted in Opti-MEM. Twenty-four hours later, the culture supernatant was replaced by anti-biotic free culture medium. After culturing for another 24 hr, the supernatant was collected and filtered through a 0.45-μm pore-size filter. The coding sequences for mouse *Prdm16* and *C/ebp-β* genes (DNAFORM) were amplified by RT-PCR. Ecotrophic retroviral vectors were constructed as above, except that PLAT-E packaging cells were used instead of PLAT-GP. The GFP retroviral vector was kindly provided by Professor S. Yamanaka of Kyoto University.

Induction of BAs from iPSCs {#sec4.3}
---------------------------

Human iPSCs were induced to differentiate into embryoid bodies by culturing in DMEM medium supplemented with 10% FBS and 25 μM RA in nonadherent culture dishes. On day 7, cells were collected, allowed to adhere to plastic dishes, and cultured for another 10 days in DMEM supplemented with 10% FBS and 50 μM RA. Cells were then transduced with the retroviral vector encoding human PRDM16, followed by further culturing in BA1 medium (10% FBS, 0.5 mM 3-isobutyl-1-methylxantine \[IBMX\], 1 μM dexamethasone, 125 nM indomethacin, 850 nM insulin, 1 nM triiodothyronine \[T3\], and 1 μM rosiglitazone) for 2 days and subsequently in BA2 medium (10% FBS, 850 nM insulin, 1 nM T3, and 1 μM rosiglitazone) for 8 days. Mouse iPSCs were cultured in DMEM/10% FBS under nonadherent conditions. RA was added to the culture medium to a final concentration of 25 μM (days 3--5) and 50 μM (days 5--7) to obtain embryoid bodies. On day 7, cells were collected and cultured for another 10 days in DMEM supplemented with 10% FBS and 50 μM RA under adherent conditions. The cells were transfected with an episomal vector containing the mouse PRDM16 gene by electroporation, followed by further culturing in BA1 medium for 2 days and in BA2 medium for 8 days.

Direct Conversion of Fibroblasts into BAs {#sec4.4}
-----------------------------------------

Human dermal fibroblasts (HDFs) were seeded onto culture dishes or plates at a density of 1.5--2.0 × 10^4^ cells/ml. On the next day, cells were transduced with various combinations of retroviral vectors ([Figures 3](#fig3){ref-type="fig"}A--3B, [S3](#mmc1){ref-type="supplementary-material"}A, and [S5](#mmc1){ref-type="supplementary-material"}) or a mixture of *C/EBP-β* and *C-MYC* retroviral vectors (*CM*) ([Figures 3](#fig3){ref-type="fig"}C--3E, [4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}, and [S3](#mmc1){ref-type="supplementary-material"}B) in the presence of 4 μg/ml polybrene (day 0). On day 1, culture supernatant was replaced by fresh type 1 medium (10% FBS, 850 nM insulin, 1 nM T3, 0.5 mM IBMX, 1 μM dexamethasone, 125 nM indomethacin, and 1 μM rosiglitazone). After culturing for 2 days, culture supernatant was replaced by type 2 medium (10% FBS, 850 nM insulin, 1 nM T3, and 1 μM rosiglitazone). Culture medium was refreshed once every 2 days. MEFs derived from C57BL/6 and KK-Ay mice were transduced with various combinations of retroviral vectors ([Figure S5](#mmc1){ref-type="supplementary-material"}A) or a mixture of *Prdm16*, *C/ebp-β*, and *L-myc* retroviral vectors (*PCL*) ([Figures 6](#fig6){ref-type="fig"}, [7](#fig7){ref-type="fig"}, and [S5](#mmc1){ref-type="supplementary-material"}B--S5E) as above.

Cell Staining {#sec4.5}
-------------

For mitochondrial staining, MitoTracker Red probe (Invitrogen) was added to the culture to a final concentration of 200 nM and cells were incubated at 37°C in 5% CO~2~/95% humidified air for 15 min. For Oil Red O staining, cells were washed with PBS (−) and fixed with 60% isopropanol. After staining with the Oil Red O solution (0.048% w/v Oil Red O in 60% isopropanol), cells were washed with 60% isopropanol followed by washing with distilled water.

Immunostaining {#sec4.6}
--------------

The cells were fixed in 4% paraformaldehyde at 4°C for 30 min. After washing with PBS, the cells were stained with the following antibodies, all at the optimally titrated dose. To stain human UCP1 and DIO2, cells were incubated with goat anti-human UCP1 (cat no. PAB6905; Abnoba) and goat anti-human DIO2 (cat no. NBP1-00178; Novus Biologicals), respectively, followed by washing and incubation with secondary antibody (either Alexa-488-labeled anti-goat IgG \[cat no. A11070; Invitrogen\] or PE-labeled anti-goat IgG \[cat no. PA1-29953; Thermo Scientific\] antibody). To stain human CIDEA, rabbit anti-human CIDEA (cat no. NBP1-46987; Novus Biologicals) and Alexa-488-labeled anti-rabbit Ig (cat no. A11070; Invitrogen) antibodies were used. Human PGC1 was stained using rabbit anti-human PGC1 (cat no. NBP1-04676; Novus Biologicals) and PE Cy5-labeled anti-rabbit IgG (cat no. sc-45110; Santa Cruz Biotechnology) antibodies. To stain mouse UCP1, CIDEA, and DIO2, cells were incubated with anti-mouse UCP1 (cat no. MAB6158; R&D Systems), rabbit anti-mouse CIDEA (cat no. PAB11960; Abnoba), and goat anti-mouse DIO2 (cat no. NBP1-0017; Novus Biologicals) antibodies, followed by staining with CF488-conjugated anti-mouse IgG (cat no. 20014; Biotium), Alexa-488-labeled anti-rabbit Ig (cat no. A11070; Invitrogen), and PE-conjugated anti-goat IgG (cat no. sc45110; Santa Cruz Biotechnology) antibodies, respectively.

Real-Time RT-PCR {#sec4.7}
----------------

Total RNA was extracted from cells using ISOGEN II (Nippon Gene) and reverse transcribed using ReverTra Ace qPCR RT Master Mix (TOYOBO). In some experiments, dBAs were stimulated with 100 nM leptin for 24 hr or 1 μl isoproterenol for 2 hr before RNA extraction. RNA was also extracted from BAT isolated from the posterior cervical region of C57Bl/6 mice. Real-time RT-PCR was carried out using Real-time PCR Master Mix (TOYOBO) and matching probes and primers on a 7300 Real-Time PCR System (Applied Biosystems). All values were normalized with respect to the *β-actin* mRNA level in each sample and expressed relative to the corresponding value in gingival fibroblasts. The primer sequences are shown in [Table S1](#mmc1){ref-type="supplementary-material"}.

DNA Microarray Analysis {#sec4.8}
-----------------------

For human cells, RNA was obtained from WAs, iBAs, and dBAs, and after reverse-transcription, microarray analyses were performed using GeneChip human Gene 1.0 ST (Affymetrix) according to the manufacturer's instruction. For mouse cells, RNA obtained from MEFs, BAT, and dBAs was reverse-transcribed and analyzed using GeneChip Mouse Genome 430 2.0 Array. Scanned data were analyzed using Expression Console (Affymetrix) and GeneSpring Ver.12.6 (Agilent Technologies) software.

Bisulfite Sequencing {#sec4.9}
--------------------

Bisulfite treatment of genomic DNA was performed using MethylCode Bisulfite Conversion Kit (Invitrogen), according to the manufacturer's instruction. The sequences corresponding to the human *UCP-1* gene upstream region (−693 to −348 bases relative to the transcription start site) and the *PPARγ* gene upstream region (−431 to −151 bases relative to the transcription start site) were amplified by PCR using primers described in [Table S2](#mmc1){ref-type="supplementary-material"}. The resultant PCR product was cloned into the pTA2 vector (TOYOBO). Ten randomly selected clones of each sample were sequenced using the T7 and T3 universal primers.

Mitochondria DNA Evaluation {#sec4.10}
---------------------------

Real-time PCR was performed using the 7300 Real-Time PCR System (Applied Biosystems). The matching primers and dye probe for the *MT-ND1* (Hs02596873_s1) and *β-ACTIN* (Hs00357333_g1) were purchased from Applied Biosystems. Copy numbers were quantified by RQ software (Applied Biosystems).

Metabolic Analyses {#sec4.11}
------------------

HDFs were transduced with *CM* retrovirus vectors as above. After cultured for 12 days, the cells were used as dBAs. To assess glucose consumption, culture supernatants of HDFs, un-stimulated dBAs, and dBAs pre-stimulated with 1 μM isoproterenol (LKT Laboratories) for 2 hr were replaced by fresh complete medium. Before and 24 hr after culture under the standard conditions, glucose concentrations in the culture supernatants were measured by the glucose B test (Wako). To determine glucose uptake, culture supernatants of HDFs and dBAs were replaced by the Krebs Ringer Phosphate HEPES buffer (1.2 mM KH~2~PO~4~, 1.2 mM MgSO~4~, 1.3 mM CaCl~2~, 118 mM NaCl, 5 mM KCl, and 30 mM HEPES \[pH 7.5\]). Eighteen min after addition of 1 μM insulin (Cell Science & Technology Institute), 2DG was added to the culture to a final concentration of 1 mM, and 30 min later, 2DG uptake was evaluated using the 2-DG Uptake Measurement Kit (CSR). Some aliquots of cells were incubated with 1 μM Antimycin (Enzo Life Science) or 1 μM isoproterenol for 4 hr before the addition of insulin, whereas other aliquots of cells were incubated with 200 μM phloretin (Wako) for 2 min before the addition of 2DG. Oxygen consumption was determined using Extracellular Flux Analyzer XF96 instrument (Seahorse Bioscience). Briefly, mitochondrial biogenesis was profiled by serially adding perturbation agents, i.e., 2 μM oligomycin (Sigma; cat no. 04876), 0.5 μM FCCP (carbonylcyanide-p-trifluoromethoxyphenylhydrazone; Sigma; cat no. C2920), and 3 μM antimycin A (Sigma; cat no. A8674), and 1 μM rotenone (Sigma; cat no. R8875) to the cells.

Transplantation {#sec4.12}
---------------

Every animal experiment was approved by the institutional Animal Experiment Committee, and care of the animals was in accordance with institutional guidelines. Male C57BL/6 and KK-Ay/Tajcl mice (Shimizu Laboratory Suppliers) at 8 weeks of age were anesthetized with an intraperitoneal injection of pentobarbital. In iBA transplantation experiments, the iBAs in two confluent 100-mm dishes were resuspended in 25 μl medium/75 μl Matrigel (BD Bioscience) and subcutaneously transplanted to the flank of syngenic mice. As control, cells were transduced with *GFP* retroviral vector instead of *Prdm16* retroviral vector and transplanted to mice as above, whereas the other control group was not transplanted. In dBA transplantation experiments, dBAs that had been induced from MEF by *PCL* retroviral vector transduction, and MEF that had been transduced with *GFP* retroviral vector as control, were transplanted to syngenic mice as above.

Diet-Induced Obesity Mouse Model {#sec4.13}
--------------------------------

Mice were housed on high-fat diet (Quick Fat; CLEA Japan) or regular chow (CE-2; CLEA Japan) as control. Diet composition (w/w %) of the high-fat diet was as follows: 24.0% crude protein; 14.6% crude fat; 2.7% crude fiber; 5.1% crude ash; 46.7% NFE; and 7.3% moisture ([@bib16]). Total calorie of the high-fat diet was 415.1 kcal/100 g. The regular chow was composed of 24.9% (w/w) crude protein, 4.6% crude fat, 4.1% crude fiber, 6.6% crude ash, 51.0% NFE, and 8.9% moisture with total calories of 344.9 kcal/100 g. Any significant difference was not observed among the amounts of food intake of all mouse groups fed high-fat diet during the experimental periods in all experiments ([Figure S7](#mmc1){ref-type="supplementary-material"}).

Thermography and Metabolic Analyses of Mice {#sec4.14}
-------------------------------------------

Thermographic imaging was obtained using a thermal imaging camera (Fliar Systems). Serum lipids were evaluated using the NEFA C Test (Wako), Triglyceride E Test (Wako), Phospholipids C Test (Wako), HDL-cholesterol E Test (Wako), and Total Cholesterol E Test (Wako). Blood glucose levels were measured using GluTest (Sanwa Kagaku). For the oral glucose tolerance test, mice were administered with 50 mg of glucose via a gastric catheter. Before and 30, 60, and 120 min after the administration, blood glucose was evaluated as above. For the insulin-resistant test, mice were intraperitoneally administered with 0.0125 U of insulin. Before and 30, 60, and 120 min after the administration, blood glucose was determined.

Statistical Analyses {#sec4.15}
--------------------

Data are expressed as average ± SD. Data in each group distributed normally, and variance was similar between the groups that were statistically compared. Statistical significance was analyzed by Student's t test (two-sided). A value of p \< 0.05 was considered significant. No statistical analysis was used to predetermine sample size. Experiments were performed in randomized and non-blind fashion. No samples or animals were excluded from the analyses. The data met the assumptions of the tests.

Accession Numbers {#app1}
=================

The accession number for the microarray data reported in this paper is GEO: [GSE52817](ncbi-geo:GSE52817){#intref0010}.

Supplemental Information {#app3}
========================
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![Human iBAs Induced from iPSCs\
(A and B) Human iPSCs were cultured in the presence of RA followed by transduction with *PRDM16* retroviral vector. After culturing for 12 days, cells were subjected to Oil Red O and mitochondrial staining (A), as well as immunostaining with the indicated antibodies (B). Original magnification was 100×.\
(C) Real-time RT-PCR was performed to evaluate mRNA levels of the indicated genes in HDFs and hiBAs.\
(D) Human dermal fibroblasts (HDFs) and human iBAs were stimulated with the indicated concentrations of isoproterenol. Twelve hours later, *UCP1* mRNA levels were evaluated by real-time RT-PCR.\
(E) Oxygen consumption of the indicated cells was evaluated. Oligomycin (O), FCCP (F), and antimycin A and rotenone (A + R) were serially added to the culture at the indicated time periods.\
In (A)--(E), n = 3 cultures per group. In (C) and (D), values (average ± SD) were normalized to *β-ACTIN* mRNA and expressed relative to values for the HDFs (set to 1.0; n = 3 cultures per group). In (E), values are average ± SD (n = 3 cultures per group). The experiments were repeated more than three times.](gr1){#fig1}

![iBAs Suppressed Diet-Induced Obesity and Diabetes in Mice\
(A and B) C57BL/6 mice were subcutaneously transplanted with syngenic iBAs or control cells that had not been transduced with *Prdm16* (d0). Two weeks after the transfection, thermographic images of mice were captured after exposure to 4°C for 2 hr (A). Mice were then sacrificed, and graft tissue sections were stained with Oil Red O (B; original magnification was 40×).\
(C and D) C57BL/6 mice were subcutaneously transplanted with syngenic iBAs or *GFP*-transduced cells as control and housed on either standard- or high-calorie diet. Body weights of mice were measured (C), and serum lipid concentrations were determined 4 weeks after transplantation (D).\
(E--H) KK-Ay diabetic mice were subcutaneously transplanted with syngenic iBAs or *GFP*-transduced fibroblasts as a control. Body weights (E) and non-fasting serum glucose levels (F) of the mice are shown. Urine glucose levels were measured 3 weeks after the transplantation (G), and serum lipid concentrations were determined 4 weeks after the transplantation (H).\
In (C)--(H), values are average ± SD (n = 8 mice per group) for one out of two independent experiments. ^∗^p \< 0.05 (two-sided Student's t test). In (A) and (B), n = 3 mice per group. The experiments were repeated more than twice. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Human Dermal Fibroblasts Were Efficiently Converted into BAs by Defined Factors\
(A and B) HDFs were transduced with the indicated retroviral vectors, and after culturing for 12 days, cells were subjected to mitochondria staining (A) and Oil Red O staining (B). Original magnification was 100×.\
(C) HDFs transduced with *C* and/or *M* retrovirus vectors were cultured for 14 days, and mRNA levels for the indicated genes were evaluated by real-time RT-PCR.\
(D) *CM*-transduced HDFs were cultured for 12 days and immunostained with the indicated antibodies (original magnification was 100×; immunostaining images were obtained using haze reduction). In (A) and (D), representative images of three independent experiments (n = 3 cultures per group) are shown.\
(E) *CM*-transduced HDFs and untransduced HDFs were cultured for 12 days and stained with DAPI (nuclear staining) and anti-UCP1 antibody as above. Proportions of UCP1-staining cells are shown as average ± SD (representative of three independent experiments; n = 3 cultures per group).\
(F) RNA was obtained from HDFs, iBAs, and *CM*-infected HDFs cultured for 12 days (dBAs). Relative mRNA levels for the indicated genes were evaluated.\
In (C) and (F), values (average ± SD) were normalized to *β-ACTIN* mRNA and expressed relative to values for the HDFs (set to 1.0). The experiments were repeated more than three times. See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Characterization of dBAs\
HDFs were transduced with *CM* retroviruses as in [Figure 3](#fig3){ref-type="fig"}D, and after culturing for 12 days, the cells were uses as dBAs.\
(A and B) RNA was extracted from HDFs, WAs, iBAs (obtained from two independent induction experiments), and dBAs (obtained from three independent induction experiments). DNA microarray analyses were performed. Heatmap and correlation coefficient values for all genes are shown (A). Among 29,096 genes tested, 3,517 genes were shown differentially expressed among the cells (greater than three folds), and heatmap and hierarchical clustering analysis of the differentially expressing genes are shown (B). Red and blue colorations indicate increased and decreased expression, respectively.\
(C) Genomic DNA was extracted from HDFs and human dBAs and tested for CpG methylation at the *PPAR-γ* and *UCP1* gene upstream regions (n = 10 plasmid clones per group). The experiments were repeated more than three times.\
See also [Table S2](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Metabolic Features of dBAs\
(A) DNA was extracted from *CM*-transduced HDFs on the indicated days after transduction. Relative copy number of *MT-ND1* was determined by real-time PCR.\
(B and C) Cells were stimulated with 100 nM leptin for 6 hr or 1 μM isoproterenol for 2 hr. mRNA for *UCP1* (B) and *LEPR* (C) genes were evaluated.\
(D) HDFs, dBAs, and dBAs pre-stimulated with isoproterenol were cultured for 24 hr. Glucose content in the supernatant was determined.\
(E) Cells were cultured with or without insulin, whereas some cell aliquots were also treated with the indicated reagents. Thirty minutes after addition of 2DG, incorporated 2DG was evaluated.\
(F) Oxygen consumption of the indicated cells was evaluated as in [Figure 1](#fig1){ref-type="fig"}E.\
Values in (A)--(F) are average ± SD (n = 3 cultures per group). The experiments were repeated more than three times.](gr5){#fig5}

![dBAs Suppressed Diet-Induced Obesity in Mice\
C57BL/6 MEFs were transduced with either *PCL* or *GFP* retroviral vectors (day −12), and the resultant cells (dBAs and GFP control, respectively) were subcutaneously transplanted into syngenic mice (day 0). These mice, as well as non-transplanted mice, were housed on either standard- or high-calorie diet.\
(A) Body weights of the mice are shown.\
(B) Two and four weeks after transplantation, oral glucose tolerance test (upper) and insulin resistance test (lower) were performed.\
(C) Serum lipid concentrations on day 28 are shown. Values are average ± SD for one out of two independent experiments (n = 8 mice per group). ^∗^p \< 0.05 (two-sided Student's t test).\
(D) Two weeks after transplantation, mice were exposed to 4C for 2 hr. Shown are thermographic images of the representative mice (n = 4 mice per group). The experiments were repeated more than twice.\
See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}A.](gr6){#fig6}

![dBAs Suppressed Diabetes in Mice\
KK-Ay MEFs were transduced with either *PCL* or *GFP* retroviral vectors (day −12) to obtain dBAs and GFP control cells, respectively. Other cells were transduced with both *PCL* and *shUCP1*. The cells were subcutaneously transplanted into syngenic mice (day 0).\
(A--C) Body weights of mice (A) as well as fasting and non-fasting serum glucose levels (B and C) of the mice are shown.\
(D--F) On day 28, oral glucose tolerance test (D) and insulin resistance test (E) were performed, while serum lipid concentrations were evaluated (F). Values are average ± SD (n = 8 mice per group). The experiments were repeated more than twice.\
See also [Table S3](#mmc1){ref-type="supplementary-material"} and [Figure S6](#mmc1){ref-type="supplementary-material"}B.](gr7){#fig7}
